Press Releases July 23, 2026 08:00 AM

Aemetis to Review Second Quarter 2026 Financial Results on August 6, 2026

Aemetis schedules conference call for Q2 2026 financial results on August 6, 2026

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
AMTX

Aemetis, Inc., a renewable natural gas and biofuels company headquartered in California, announced a conference call to discuss its second quarter 2026 financial results scheduled for August 6, 2026. The company operates ethanol and biodiesel production facilities and is developing additional renewable energy projects, including sustainable aviation fuel and CO2 sequestration.

Aemetis to Review Second Quarter 2026 Financial Results on August 6, 2026
AMTX
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Conference call to review Q2 2026 earnings set for August 6, 2026.
  • Aemetis operates multiple renewable fuel production facilities including ethanol and biodiesel plants in California and India.
  • The company is expanding into sustainable aviation fuel production and carbon capture initiatives.
  • Sectors impacted: Renewable energy, biofuels, agriculture, environmental technology.

CUPERTINO, Calif., July 23, 2026 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its second quarter 2026 earnings report:

Date: Thursday, August 6, 2026

Time: 11 am Pacific Time (PT)

Live Participant Dial In (Toll Free): +1-888-506-0062 entry code 423338

Live Participant Dial In (International): +1-973-528-0011 entry code 423338

Webcast URL: https://www.webcaster5.com/Webcast/Page/2211/54334

Attendees may submit questions during the Q&A (Questions & Answers) portion of the conference call.

The webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls, along with the company presentation, recent announcements, and video recordings.

The voice recording will be available through August 20,2026 by dialing (Toll Free) 877-481-4010 or (International) 919-882-2331 and entering conference ID number 54334. After August 20th, the webcast will be available on the Company’s website (www.aemetis.com) under Investors/Conference Calls.

About Aemetis

Headquartered in Cupertino, California, Aemetis is a diversified renewable natural gas and biofuels company focused on the development and operation of innovative technologies that lower energy costs and reduce emissions. Founded in 2006, Aemetis is operating and expanding a California biogas digester network and pipeline system to convert dairy waste gas into Renewable Natural Gas. Aemetis owns and operates a 65 million gallon per year ethanol production facility in California’s Central Valley near Modesto that supplies about 80 dairies with animal feed. Aemetis owns and operates an 80 million gallon per year production facility on the East Coast of India producing high quality biodiesel and refined glycerin. To utilize the byproducts from ethanol production, Aemetis is developing a sustainable aviation fuel plant and a CO2 sequestration project in California. For additional information about Aemetis, please visit www.aemetis.com. 

Investor Relations/Media Contact:
Todd Waltz
(408) 213-0940
[email protected]

External Investor Relations Contact:
Kirin Smith
PCG Advisory Group
(646) 863-6519
[email protected]


Risks

  • Uncertainty about financial performance as results are yet to be released.
  • Dependence on regulatory policies and subsidies in renewable energy and biofuels sectors.
  • Market risks related to commodity prices impacting biofuel and feedstock costs.

More from Press Releases

Zhihu Inc. Announces Proposed Subscription in AI-Focused Investment Fund Sep 6, 2026 Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call Sep 6, 2026 Verizon Waives Charges for Hurricane Lowell, Prepares Network in Hawai'i Sep 5, 2026 Royalty Pharma announces update on Novartis’ Phase 3 topline results for pelacarsen Sep 4, 2026 Grupo Aeroportuario del Pacifico Reports a Passenger Traffic Increase in August 2026 of 0.5% Compared to 2025 Sep 4, 2026